This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.

Androderm, Testosterone Transdermal System

Take the T QuizPrescribing Information
The Drive is Back
HomeWhat is Testosterone Deficiency?What is Androderm?Take the T QuizInfo for Healthcare ProfessionalsContact Us
Why Should I choose Androderm?How Do I Use Androderm?How Do I Apply Androderm?
How Do I Apply Androderm?

Easy application in 3 easy steps

Choose an appropriate skin location based on the directions above.
Then follow these easy steps.

diagram of application process
  1. Open the pouch. Open the foil patch pouch by tearing along the edge and take out the patch.
  2. Remove protective liner and silver disc from the patch. Grasp the tabs on the patch and on the protective plastic liner. Pull the 2 tabs apart to separate the liner and silver disc from the patch. This will expose the adhesive and reservoir area. Discard the clear plastic liner and silver disc.
  3. Apply the patch to an appropriate place. Place the patch's sticky side down and press firmly around the edges to attach to skin. Make sure it sticks firmly and is in full contact with the skin for proper absorption of testosterone from the reservoir.

 

Safety Information

If you are over 55 years of age, treatment with androgens (such as testosterone) may increase the risk of benign enlargement of the prostate and may promote the growth of existing cancer of the prostate. While using Androderm, some patients may experience skin irritation at the application site. To reduce the risk of such irritation, the patch should not be applied to the same place more than once a week. If irritation occurs and persists in spite of rotating the patch, it may be ameliorated by applying 0.1% triamcinolone acetonide cream. Androderm must not be used by women. Androderm should not be used by men who have breast cancer or by men who are suspected to have cancer of the prostate. Also, Androderm should not be used by men who are hypersensitive to any of the patch components. Adverse events reported by > 5% of patients in clinical trials of Androderm (n=122): pruritus at application site, 37%; burn-like blister reaction under system, 12%; erythema at application site, 7%; vesicles at application site, 6%; prostate abnormalities, 5%. In geriatric patients, treatment with testosterone may increase the risk of developing benign prostatic hyperplasia and may promote the growth of existing prostate cancer. Androderm should not be applied over bony prominences or over areas subject to prolonged pressure. Androderm must not be used in women.

Please see Prescribing Information.

+ References

 

[1] Androderm® Physician Prescribing Information
[2] Androderm® Patient Prescribing Information
[3] Petak SM. ACCE Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocr Pract 2002;8: 439-459.
[4] Meikle AW, Arver S, Dobs AS, et al. Pharmacokinetics and Metabolism of a Permeation-Enhanced Testosterone Transdermal System in Hypogonadal Men: Influence of Application Site - A Clinical Research Center Study. J Clin Endocrinol Metab1996;81:1832-1840.
[5] Kaufman JM, Vermeulen A. Declining gonadal function in elderly men. Bailiere's Clin Endocrinol Metab 1997;11:289-309.
Þ Includes free, albumin-bound, and SHBG-bound testosterone.
‡ As determined by equilibrium dialysis.
* Clinical significance is unknown.

  

Physician
Patient
languages
languages